Durvalumab-based Treatment Before and After Surgery Improved Outcomes for Patients With Resectable Non-small Cell Lung Cancer
Patients treated with the durvalumab-based regimen before and after surgery in the AEGEAN trial had a 32% reduction in...
Patients treated with the durvalumab-based regimen before and after surgery in the AEGEAN trial had a 32% reduction in...
ORLANDO, Fla. – Adjuvant therapy with atezolizumab (Tecentriq) and bevacizumab (Avastin) increased recurrence-free survival of patients with hepatocellular carcinoma...
Clinical benefit was independent of patients’ tumor mutational burden ORLANDO, Fla. – mRNA-4157/V940, a personalized mRNA-based cancer vaccine,...
Disaggregating statistics revealed key differences in ethnic populations ORLANDO, Fla. – An analysis of lung cancer incidence rates showed...
Most people are also not aware that HPV can cause anal, oral, and penile cancers ORLANDO, Fla. – Americans...
REGN5459 had decreased binding affinity to T cells, resulting in an encouraging side effect profile and efficacy ORLANDO, Fla....
The American Association for Cancer Research (AACR) will host its 114th Annual Meeting from April 14-19, 2023, at the Orange...
Press conference schedule is announced; housing deadline less than a month away The American Association for Cancer Research (AACR)...
The American Association for Cancer Research (AACR) will host its 114th Annual Meeting from April 14-19, 2023, at the Orange...
ORLANDO, Fla. – More than 30 articles of advances in cancer research will be presented at the AACR Annual...
Media luncheon and additional details regarding press operations also announced PHILADELPHIA – The American Association for Cancer Research (AACR)...
June is National Cancer Survivor Month and Cancer Immunotherapy Month, spearheaded by the Cancer Research Institute. To support and...
WHAT: The American Association for Cancer Research (AACR) and the National Cancer Institute (NCI) will host a media briefing...
Awardees will receive $5,000 unrestricted cash prize PHILADELPHIA — The American Association for Cancer Research (AACR) is inviting journalists...
Awardees will receive $5,000 cash prize PHILADELPHIA – The American Association for Cancer Research (AACR) invites journalists to submit...
Journalists have three weeks left to submit a story for a chance to win $5,000 PHILADELPHIA – The American...
Submission deadline is in six weeks; awardees will receive $5,000 unrestricted cash prize PHILADELPHIA – The American Association for...
Journalists have one week to submit a story for a chance to win $5,000 PHILADELPHIA – Journalists have one...
Dr. Siu is a senior medical oncologist, director of the Phase I Clinical Trials Program, codirector of the Robert...
Dr. Vonderheide, MD, DPhil, is is a distinguished laboratory scientist, clinician, and cancer leader who has deciphered mechanisms of...
Susan M. Love, MD, MBA, a breast cancer surgeon who revolutionized patient care and advocacy, died July 2, 2023,...
Jeffrey W. Pollard, PhD, a member of the AACR whose work contributed to improved understanding of the biology of...
Soldano Ferrone, MD, PhD, a pioneering cancer immunologist, died January 10, 2023, at the age of 82. Ferrone was...
Gloria M. Petersen, PhD, a respected genetic epidemiologist and pancreatic cancer researcher, died January 8, 2023, at the age...
Between April 5 – 10, the AACR Annual Meeting 2024 will welcome leading cancer scientists from all over the...
Between April 14 – 19, the AACR Annual Meeting 2023 will welcome the best cancer scientists from all over...
The AACR Annual Meeting 2024 took place April 5–10 at the San Diego Convention Center in California, with over...
Please join us for an interactive session taking place Monday, April 17th, at the AACR Annual Meeting 2023. The...
We are extremely proud of our past and present grantees who presented and published their findings this past year....
Smoking is the leading preventable cause of cancer (1). On May 31st, World No Tobacco Day, smokers all over...